Quest Cash Per Share from 2010 to 2024

DGX Stock  USD 163.32  1.05  0.65%   
Quest Diagnostics Cash Per Share yearly trend continues to be fairly stable with very little volatility. Cash Per Share is likely to outpace its year average in 2024. During the period from 2010 to 2024, Quest Diagnostics Cash Per Share regression line of annual values had r-squared of  0.50 and arithmetic mean of  3.43. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
6.125
Current Value
6.43
Quarterly Volatility
3.10299607
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of Quest Diagnostics Incorporated over the last few years. It is Quest Diagnostics' Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 6.15 X10 Years Trend
Slightly volatile
   Cash Per Share   
       Timeline  

Quest Cash Per Share Regression Statistics

Arithmetic Mean3.43
Geometric Mean2.22
Coefficient Of Variation90.51
Mean Deviation2.70
Median1.86
Standard Deviation3.10
Sample Variance9.63
Range8.5383
R-Value0.71
Mean Square Error5.14
R-Squared0.50
Significance0
Slope0.49
Total Sum of Squares134.80

Quest Cash Per Share History

2024 6.43
2023 6.13
2022 2.72
2021 7.33
2020 8.64
2019 8.9

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Cash Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Per Share 6.13  6.43 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.